FY17
Assets46.86
Net Worth7.58
Total Debt11.57
RevenueAnnualised basis67.66
EBITDAAnnualised basis6.50
PATAnnualised basis2.92
EBITDA Margin (%)9.61
At a glance
Updated 2026-09-06ANG Lifesciences India is an IPO with an issue size of ₹12.01 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹12.01 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets25.84₹ Cr · -27.2% vs prior year
Net Worth3.12₹ Cr · -34.5% vs prior year
FY16
Assets35.49
Net Worth4.76
Total Debt11.76
RevenueAnnualised basis54.92
EBITDAAnnualised basis4.92
PATAnnualised basis1.65
EBITDA Margin (%)8.96
FY15
Assets25.84
Net Worth3.12
Total Debt10.14
RevenueAnnualised basis36.84
EBITDAAnnualised basis3.19
PATAnnualised basis0.40
EBITDA Margin (%)8.66
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| ANG Lifesciences India IPO | — | 14.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track ANG Lifesciences India without missing an update
Register for subscription, GMP, allotment and listing notifications.